{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:11:38Z","timestamp":1794370298740,"version":"4.9.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:00:00Z","timestamp":1716940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ygyno.2024.05.027","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T17:25:31Z","timestamp":1717435531000},"page":"241-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Comprehensive next-generation sequencing identifies novel putative pathogenic or likely pathogenic germline variants in patients with concurrent tubo-ovarian and endometrial serous and endometrioid carcinomas or precursors"],"prefix":"10.1016","volume":"187","author":[{"given":"Omonigho","family":"Aisagbonhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Ghlichloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan S.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Roma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwole","family":"Fadare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramez","family":"Eskander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Saenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Fisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2024.05.027_bb0005","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3390\/ijms20040952","article-title":"High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints","volume":"20","author":"Lisio","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ygyno.2024.05.027_bb0010","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3322\/caac.21456","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2024.05.027_bb0015","series-title":"Female genital tumors. IARC Lyon (France). WHO classification of tumors series","first-page":"32","article-title":"Tumors of the ovary: introduction chapter 1, tumors of the ovary","author":"McCluggage","year":"2020"},{"key":"10.1016\/j.ygyno.2024.05.027_bb0020","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/modpathol.2016.238","article-title":"Serous tubal intraepithelial neoplasia: the concept and its application","volume":"30","author":"Meserve","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2024.05.027_bb0025","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/cncr.29321","article-title":"Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer","volume":"121","author":"Walker","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2024.05.027_bb0030","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2005.04.5260","article-title":"ASCO\/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes","volume":"24","author":"Guillem","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2024.05.027_bb0035","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2024.05.027_bb0040","author":"Daly"},{"key":"10.1016\/j.ygyno.2024.05.027_bb0045","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ygyno.2024.05.027_bb0050","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ygyno.2024.05.027_bb0055","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1038\/ncomms4156","article-title":"Integrated analysis of germline and somatic variants in ovarian cancer","volume":"5","author":"Kanchi","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ygyno.2024.05.027_bb0060","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s12913-020-05318-y","article-title":"Estimating the cost of genomic sequencing in cancer control","volume":"20","author":"Gordon","year":"2020","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.ygyno.2024.05.027_bb0065","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/cncr.34056","article-title":"Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics","volume":"128","author":"Bychovsky","year":"2022","journal-title":"Cancer"},{"issue":"Supplement","key":"10.1016\/j.ygyno.2024.05.027_bb0070","first-page":"S1150","article-title":"Risk factors for early-stage high-grade serous carcinoma and precursor lesions in the era of opportunistic salpingectomies","volume":"104","author":"Ghlichloo","year":"2024","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ygyno.2024.05.027_bb0075","author":"Illumina"},{"key":"10.1016\/j.ygyno.2024.05.027_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77218-4","article-title":"Accuracy and efficiency of germline variant calling pipelines for human genome data","volume":"10","author":"Zhao","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ygyno.2024.05.027_bb0085","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"The Cancer Genome Atlas Research Network","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2024.05.027_bb0090","doi-asserted-by":"crossref","first-page":"12976","DOI":"10.3390\/ijms222312976","article-title":"Focal point of Fanconi anemia signaling","volume":"22","author":"Zhan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ygyno.2024.05.027_bb0095","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40246-015-0054-y","article-title":"Update of the human and mouse Fanconi anemia genes","volume":"9","author":"Dong","year":"2015","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.ygyno.2024.05.027_bb0100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.humpath.2017.08.038","article-title":"GLI1 is a potential cancer stem cell marker and predicts poor prognosis in ductal breast carcinoma","volume":"69","author":"Ni","year":"2017","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ygyno.2024.05.027_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060145","article-title":"Expression of the glioma-associated oncogene homolog 1 (gli1) in advanced serous ovarian cancer is associated with unfavorable overall survival","volume":"8","author":"Ciucci","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2024.05.027_bb0110","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","article-title":"AACR project GENIE: powering precision medicine through an international consortium","volume":"7","author":"The AACR Project GENIE Consortium","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ygyno.2024.05.027_bb0115","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.neo.2021.06.010","article-title":"Hedgehog\/GLI1 transcriptionally regulates FANCD2 in ovarian tumor cells: its inhibition induces HR-deficiency and synergistic lethality with PARP inhibition","volume":"23","author":"Mani","year":"2021","journal-title":"Neoplasia"},{"key":"10.1016\/j.ygyno.2024.05.027_bb0120","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.3390\/ijms241612665","article-title":"The role of PIK3R1 in metabolic function and insulin sensitivity","volume":"24","author":"Tsay","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ygyno.2024.05.027_bb0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-019-0954-x","article-title":"Targeting PI3K in cancer: mechanisms and advances in clinical trials","volume":"18","author":"Yang","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ygyno.2024.05.027_bb0130","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1158\/2159-8290.CD-11-0039","article-title":"High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability","volume":"1","author":"Cheung","year":"2011","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.ygyno.2024.05.027_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2023.194992","article-title":"The functions of FOXP transcription factors and their regulation by post-translational modifications","volume":"1866","author":"Gao","year":"2023","journal-title":"Biochim. Biophys. Acta Gene. Regul. Mech."},{"key":"10.1016\/j.ygyno.2024.05.027_bb0140","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1073\/pnas.1711335115","article-title":"Foxp1 controls mature B cell survival and the development of follicular and B-1 B cells","volume":"115","author":"Patzelt","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.ygyno.2024.05.027_bb0145","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160432","article-title":"Regulation of PI3K effector signaling by the phosphoinositide phosphatases","volume":"37","author":"Rodgers","year":"2017","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ygyno.2024.05.027_bb0150","doi-asserted-by":"crossref","first-page":"10548","DOI":"10.18632\/oncotarget.3307","article-title":"Loss of INPP4B causes a DNA repair defect through loss of BRCA1, ATM and ATR and can be targeted with PARP inhibitor treatment","volume":"6","author":"Ip","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2024.05.027_bb0155","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00412-011-0310-4","article-title":"H3.5 is a novel hominid-specific histone H3 variant that is specifically expressed in the seminiferous tubules of human testes","volume":"120","author":"Schenk","year":"2011","journal-title":"Chromosoma"},{"key":"10.1016\/j.ygyno.2024.05.027_bb0160","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.7150\/jca.46174","article-title":"Identification of the mutational landscape of gynecological malignancies","volume":"11","author":"Chava","year":"2020","journal-title":"J. Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2024.05.027_bb0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s13193-020-01271-8","article-title":"Molecular signatures of gynecological cancers: clinicians perspective","volume":"12","author":"Shylasree","year":"2021","journal-title":"Indian J. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2024.05.027_bb0170","article-title":"Molecular profiles and tumor mutational burden analysis in Chinese patients with gynecologic cancers","volume":"8","author":"Wang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ygyno.2024.05.027_bb0175","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cell.2018.03.039","article-title":"Pathogenic germline variants in 10,389 adult cancers","volume":"173","author":"Huang","year":"2018","journal-title":"Cell"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824002506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824002506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T13:42:38Z","timestamp":1745329358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824002506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":35,"alternative-id":["S0090825824002506"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.05.027","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive next-generation sequencing identifies novel putative pathogenic or likely pathogenic germline variants in patients with concurrent tubo-ovarian and endometrial serous and endometrioid carcinomas or precursors","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}